Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2013 2
2014 5
2015 2
2017 2
2019 1
2020 2
2021 4
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
[COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities].
Perkhofer L, Grünke P, Gashi-Ymeri E, Grünke T, Kroschel J, Michel D, Pensel E, Rost A, Denkinger M, Dallmeier D, Seufferlein T. Perkhofer L, et al. Among authors: kroschel j. Z Gerontol Geriatr. 2021 Aug;54(5):463-470. doi: 10.1007/s00391-021-01931-6. Epub 2021 Jul 14. Z Gerontol Geriatr. 2021. PMID: 34259902 Free PMC article. German.
BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA.1 in young adults.
Seidel A, Zanoni M, Groß R, Krnavek D, Erdemci-Evin S, von Maltitz P, Albers DPJ, Conzelmann C, Liu S, Weil T, Mayer B, Hoffmann M, Pöhlmann S, Beil A, Kroschel J, Kirchhoff F, Münch J, Müller JA. Seidel A, et al. Among authors: kroschel j. Front Immunol. 2022 Jul 25;13:882918. doi: 10.3389/fimmu.2022.882918. eCollection 2022. Front Immunol. 2022. PMID: 35958601 Free PMC article.
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
Groß R, Zanoni M, Seidel A, Conzelmann C, Gilg A, Krnavek D, Erdemci-Evin S, Mayer B, Hoffmann M, Pöhlmann S, Liu W, Hahn BH, Beil A, Kroschel J, Jahrsdörfer B, Schrezenmeier H, Kirchhoff F, Münch J, Müller JA. Groß R, et al. Among authors: kroschel j. EBioMedicine. 2022 Jan;75:103761. doi: 10.1016/j.ebiom.2021.103761. Epub 2021 Dec 17. EBioMedicine. 2022. PMID: 34929493 Free PMC article. Clinical Trial.
Global Cropland Connectivity: A Risk Factor for Invasion and Saturation by Emerging Pathogens and Pests.
Xing Y, Hernandez Nopsa JF, Andersen KF, Andrade-Piedra JL, Beed FD, Blomme G, Carvajal-Yepes M, Coyne DL, Cuellar WJ, Forbes GA, Kreuze JF, Kroschel J, Kumar PL, Legg JP, Parker M, Schulte-Geldermann E, Sharma K, Garrett KA. Xing Y, et al. Among authors: kroschel j. Bioscience. 2020 Jul 29;70(9):744-758. doi: 10.1093/biosci/biaa067. eCollection 2020 Sep. Bioscience. 2020. PMID: 32973407 Free PMC article.
26 results